NRF2 pathway activation attenuates ageing-related renal phenotypes due to α-klotho deficiency

Mingyue Zhao1, Shohei Murakami1, Daisuke Matsumaru1

  • 1Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Journal of Biochemistry
|February 9, 2022
PubMed

Insights

Activating the KEAP1-NRF2 pathway combats aging by reducing oxidative stress. This approach improved lifespan and kidney function in mice lacking the aging suppressor protein alpha-Klotho.

Area of Science:

  • Gerontology and cellular aging research.
  • Molecular mechanisms of oxidative stress regulation.

Background:

  • Oxidative stress contributes significantly to age-related cellular and tissue dysfunction.
  • The KEAP1-NRF2 system regulates redox balance, with NRF2 activation showing anti-aging potential.
  • Alpha-Klotho (a key aging suppressor) deficiency leads to premature aging phenotypes, partly due to increased oxidative stress.

Purpose of the Study:

  • To investigate if NRF2 pathway activation can counteract the aging phenotypes associated with alpha-Klotho deficiency.
  • To determine the role of NRF2 in mitigating oxidative stress in the context of alpha-Klotho deficiency.

Main Methods:

  • Generation of alpha-Klotho-deficient (Kl-/-) mice with a constitutively activated NRF2 pathway (Keap1-knockdown).
  • Assessment of lifespan and age-related phenotypes, particularly in the kidneys.
  • Analysis of antioxidant gene expression and oxidative stress markers.

Main Results:

  • NRF2 pathway activation in Kl-/- mice significantly extended lifespan.
  • Marked improvement in age-related renal phenotypes was observed in these mice.
  • Elevated antioxidant gene expression and decreased oxidative stress correlated with the observed phenotypic improvements.

Conclusions:

  • NRF2 activation effectively antagonizes aging-related phenotypes caused by alpha-Klotho deficiency.
  • The antioxidant effects of NRF2 play a crucial role in attenuating age-related kidney dysfunction.
  • NRF2 is a potential therapeutic target for anti-aging strategies, partly by compensating for declining alpha-Klotho function.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
271
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K